expansion
1215 Results
Búsqueda avanzada
Mostrar
-
-
Cellvento® 4CHO-X COMP | Cellvento CHO Cell Culture Media and Feeds | Cell Culture Media | Merck
Cellvento® 4CHO-X Expansion Medium has been developed for N-1 perfusion for CHO cell lines. It is formulated with a high nutrient concentration to achieve low cell specific perfusion rates (CSPRs) at high cell densities, and to support growth during the entire seed train. -
Press Release: Merck Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service
Merck, today announced expansion of its Provantage® Biodevelopment Services to include a Clone Generation Service. With this addition, the Company now provides a full range of services for optimizing yield, productivity, consistency and efficiency of clinical scale drug products. -
Press Release: Merck Expands Portfolio of Certified Reference Materials for Applied Diagnostics and Testing
Merck today announced the expansion of its portfolio of Cerilliant® certified reference materials (CRMs) with nine new Certified Spiking Solutions® used in laboratories around the world. -
Press Release: Merck Expands Production Know-how to Deliver Full End-To-End Solution for Biopharma Industry
Merck today announced the expansion of its state-of-the art single use current good manufacturing process (cGMP) facility with the addition of the Mobius® 2000L single-use bioreactor. -
Press Release: Merck Expands Provantage® Upstream Bioproduction Services to the North American Market
Merck, today announces the expansion of its upstream services into North America as part of its Provantage® Biodevelopment and Clinical Supply offering. -
Press Release: Merck Builds on Leading Viral and Gene Therapy Service Offering with Capacity Expansion
Merck today announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products. -
In the News - Further Expansion in the Chinese Market | Merck
News Article: Further Expansion in the Chinese Market - Interview with Udit Batra, CEO and President of Merck -
Press Release: Merck Expands its EMPROVE® Raw Materials Portfolio to 400 Products
Merck, today announced the expansion of its EMPROVE® raw materials portfolio to 400 active pharmaceutical ingredients, excipients and biopharmaceutical materials. -
Upstream Bioprocessing - From Pre-clinical to Manufacturing | Biopharmaceutical Manufacturing | Merck
Tips and best practices for mAb upstream process development and manufacturing.